Aniketh Bishnu
Overview
Explore the profile of Aniketh Bishnu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
25
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Longo M, Bishnu A, Risiglione P, Montava-Garriga L, Cuenco J, Sakamoto K, et al.
Mol Cell
. 2024 Nov;
84(22):4350-4367.e9.
PMID: 39532100
Mitophagy degrades damaged mitochondria, but we show here that it can also target functional mitochondria. This latter scenario occurs during programmed mitophagy and involves the mitophagy receptors NIX and BNIP3....
2.
Phadte P, Bishnu A, Dey P, M M, Mehrotra M, Singh P, et al.
J Exp Clin Cancer Res
. 2024 Aug;
43(1):222.
PMID: 39123206
Background: The mechanisms enabling dynamic shifts between drug-resistant and drug-sensitive states in cancer cells are still underexplored. This study investigated the role of targeted autophagic protein degradation in regulating ovarian...
3.
Bishnu A, Mehrotra M, Dhadve A, Dimri S, De A, Ray P
Transl Oncol
. 2021 Aug;
14(11):101193.
PMID: 34365218
Therapy induced rewiring of signalling networks often lead to acquirement of platinum-resistance, thereby necessitating the use of non-platinum agents as second-line treatment particularly for epithelial ovarian cancer (EOC). A prior...
4.
Bishnu A, Phadte P, Dhadve A, Sakpal A, Rekhi B, Ray P
Cell Death Dis
. 2021 Feb;
12(2):161.
PMID: 33558461
Alterations in key kinases and signaling pathways can fine-tune autophagic flux to promote the development of chemoresistance. Despite empirical evidences of strong association between enhanced autophagic flux with acquired chemoresistance,...
5.
Prajapati M, Bishnu A, Ray P, Vavia P
AAPS PharmSciTech
. 2019 Oct;
20(8):317.
PMID: 31605252
The present work aims to develop folate-targeted paclitaxel liposome (F-PTX-LIP), which will selectively target tumor cells overexpressing folate receptor (FR) and leave normal cells. Liposomes were prepared by thin-film hydration...
6.
Bishnu A, Sakpal A, Ghosh N, Choudhury P, Chaudhury K, Ray P
Int J Biochem Cell Biol
. 2018 Dec;
107:116-127.
PMID: 30593952
Development of resistance poses a significant challenge to effective first-line platinum based therapy for epithelial ovarian cancer patients. Cancer Stem Cells are envisaged as a critical underlying factor for therapy...